Oct/15/2009 05:41 Filed in:
DTC
Effectiveness
Good is the
enemy of great and, at a time when the drug
industry is under so much scrutiny, pharma can
ill afford to spend just enough money on
acquiring patients to fail miserably. Spending
money on search engine optimization without a
clear call to action and a way to measure your
dollars is a recipe for someone to say "I told
you so" as your digital efforts fall
short. Read
More...
Tags: Budgets
Sep/27/2009 06:54 Filed in:
DTC
Effectiveness
With DTC
spending down by double digits a lot of DTC
marketers are going to be facing the reality of
doing more with less next year. Someone recently
asked me "can you launch a brand online?" and my
answer to that is absolutely. Not only can you
launch a new pharma product online but I can
reach more people online and get a better ROI
through interactive than with ANY other
channel. Read
More...
Tags: Budgets
Sep/16/2009 05:57 Filed in:
DTC
Environment
There are two
stories this week which possible point to a
demise, or at the very least a big cutback, in
DTC spending. The first was that Lunesta sales
continue to rise despite the fact they are not
doing any major DTC advertising. The second was
the announcement of 5,500 layoffs at Lilly as
drugs in the pipeline fail and the impending loss
of $1 billion in sales from the loss of Zyprexa
as it comes off patent. If you think cuts in DTC
this year were bad just wait till 2010.
Read
More...
Tags: Budgets
